| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.UROLONC.2010.02.012 |
| P698 | PubMed publication ID | 20451422 |
| P50 | author | Yair Lotan | Q61862568 |
| P2093 | author name string | Raheela Ashfaq | |
| Richard Ho | |||
| Bruce J Schlomer | |||
| Ramy F Youssef | |||
| Arthur I Sagalowsky | |||
| P2860 | cites work | Cancer statistics, 2008 | Q27860585 |
| Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses | Q34174003 | ||
| Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer | Q34978029 | ||
| Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers | Q36363221 | ||
| Economic impact of tumor markers in bladder cancer surveillance | Q37074669 | ||
| Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder | Q37142679 | ||
| EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder | Q37158767 | ||
| Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy | Q37540810 | ||
| Prospective validation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder | Q37632941 | ||
| Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology | Q38452177 | ||
| Prognostic significance of nondiagnostic molecular changes in urine detected by UroVysion fluorescence in situ hybridization during surveillance for bladder cancer | Q46839842 | ||
| A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma | Q73062815 | ||
| Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor | Q73557222 | ||
| Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings | Q79517685 | ||
| FISH: a tool we really need? | Q80116576 | ||
| Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year | Q80943508 | ||
| Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice | Q81479508 | ||
| Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples | Q81637608 | ||
| Reflex UroVysion testing in suspicious urine cytology cases | Q83612735 | ||
| Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria | Q83925403 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bladder cancer | Q504775 |
| P304 | page(s) | 273-277 | |
| P577 | publication date | 2010-05-06 | |
| P1433 | published in | Urologic Oncology | Q2113446 |
| P1476 | title | Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology | |
| P478 | volume | 30 |
| Q36340124 | A prospective comparison of UroVysion FISH and urine cytology in bladder cancer detection |
| Q39543320 | Adenoviral infectivity of exfoliated viable cells in urine: implications for the detection of bladder cancer. |
| Q89184326 | An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer |
| Q91669861 | Application of fluorescence in situ hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population |
| Q51297927 | Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma. |
| Q64954033 | Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results. |
| Q57559955 | Economics of bladder cancer |
| Q54449190 | Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer. |
| Q37238810 | Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation |
| Q82339590 | Fluorescence in situ hybridization in the diagnosis of urothelial carcinoma |
| Q26851377 | From cytomorphology to molecular pathology: maximizing the value of cytology of lymphoproliferative disorders and soft tissue tumors |
| Q38970783 | Improving diagnostic molecular tests to monitor urothelial carcinoma recurrence |
| Q52724204 | Performance of the UroVysion® FISH assay for the diagnosis of malignant effusions using two cutoff strategies. |
| Q48292323 | The value of the UroVysion® FISH assay in the risk-stratification of patients with "atypical urothelial cells" in urinary cytology specimens |
| Q45139625 | Urine cytology - update 2013. A systematic review of recent literature |
Search more.